I agree with Imspartacus and others that the half year result is...

I agree with Imspartacus and others that the half year result is impressive and that it confirms the great work being done by Ellis and his team. The fundamentals are right and encourage all investors to have belief that the results will continue to be strong.
I'm not sure however of the predictions of $17m in revenues for the full year with "only" $7.5 for the first half and with talk of exiting parts of the Medivet business I think that it will be a stretch. Having said that, I think that the net profit result has the distinct possibility of being a pleasant surprise. I base this on two things: firstly, comments have been made before about write downs and provisions and while these have no doubt negatively impacted the results so far this year it is hard to imagine that they will be repeated in the second half; secondly, look at performance of the human health business - almost $900k net profit in 6 months when all that previous management could do was rack up losses year after year. I think $800k plus for the combined business is a distinct possibility IMHO.
It would be nice to get more of an understanding about what is happening in the Medivet Biologics side of the business. This was much hyped before the acquisition and reading between the lines I'm not sure that it has delivered anywhere near what was promised. I'm guessing that stripping back the business to a sole focus on stem cell therapy is a good thing and while there might be short term pain in doing so, the longer term should be bright. Also, if you look on the medivet Biologics website (www.medivetbiologics.com/home/vets/pipeline/ ) there are three studies underway which we haven't heard much about yet - one in particular that is in a new area: Atopic Dermatitis. There are also two areas currently in pre-clinical trial stage that have yet to be spoken about. This sort of work isn't cheap and I assume that this is where some of the cash is going.
During the capital raising there was talk about possible acquisitions. I think that if Ellis can find the right business to add to the human health side then the combination could really deliver some truly outstanding results. Let's wait and see.